
Medorab Injection
Marketer
Medofy Pharmaceutical
Salt Composition
Rabeprazole (20mg)
Overview Medorab Injection
Acid-reducing injection, GastriGone, effectively lowers stomach acid production. It treats acid-related gastrointestinal disorders like acid reflux, indigestion, peptic ulcers, and other conditions stemming from excessive acid. GastriGone offers rapid relief from acidity symptoms. It also prevents stress ulcers in critically ill patients and is administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous medication is administered by a healthcare professional only when deemed more appropriate than oral medication. Dosage depends on individual needs and response, determined by your physician who will also set the treatment duration. Continue the prescribed course even if symptoms subside quickly. Smaller, more frequent meals and avoiding caffeine, spicy, and fatty foods can enhance treatment efficacy. Common, typically mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects require medical consultation. Prolonged use (over a year) may increase bone fracture risk, particularly at higher doses. Discuss bone loss prevention strategies, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low blood magnesium) has been reported after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor magnesium levels. GastriGone is unsuitable for individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or breastfeeding individuals should consult their doctor. Alcohol consumption should be avoided due to its acid-producing effect. Refrain from operating machinery if dizziness or sleepiness occurs.
Uses of Medorab Injection
Management of heartburn and peptic ulcers
Major Benefits of Medorab Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Medorab Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Medorab Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Medorab Injection works:
Gastric acid production is decreased by Medorab Injection, a proton pump inhibitor (PPI), providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use of Medorab Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Medorab Injection's safety during pregnancy is uncertain. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks and advantages before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Medorab Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Medorab Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Medorab Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Medorab Injection requires careful administration in individuals with advanced hepatic impairment. Dosage modification for Medorab Injection may be necessary. Physician consultation is advised.
What if you forget to take Medorab Injection :
Should you forget a Medorab Injection dose, seek your physician's advice.
Facts to Know About Medorab Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
